☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Sanofi
Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases
April 3, 2025
Sanofi and Regeneron’s Dupixent Receives the MHLW’s Approval to Treat Chronic Obstructive Pulmonary Disease (COPD)
March 28, 2025
Sanofi Reports the US FDA’s Acceptance & Priority Review of Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosi...
March 25, 2025
Sanofi to Acquire Dren Bio’s Bispecific Antibody DR-0201 for ~$1.9B
March 20, 2025
Sanofi and J&J Discontinue P-III (E.mbrace) Study of ExPEC9V for Invasive E. coli Diseases
February 14, 2025
Sanofi Receives China’s NMPA Approval for Sarclisa + SoC VRd to Treat Newly Diagnosed Multiple Myeloma (NDMM)
January 31, 2025
Load more...
Back to Home
Modal title
×
Modal body text goes here.